White Matter Indices of Medication Response in Major Depression: A Diffusion Tensor Imaging Study

Area of Science:

• Neuroimaging
• Psychiatry
• Biomarkers

Background:

• Predicting antidepressant response in major depressive disorder (MDD) is challenging.
• White matter integrity, assessed via diffusion tensor imaging (DTI), may offer predictive biomarkers.
• Understanding these biomarkers can improve treatment selection for MDD.

Purpose of the Study:

• To investigate if DTI metrics of white matter organization can differentiate between antidepressant responders and nonresponders in MDD.
• To identify specific white matter regions and DTI measures associated with treatment response.
• To explore the temporal stability of these DTI measures during antidepressant treatment.

Main Methods:

• Collected DTI data from 200 MDD patients and 112 controls across 6 sites (CAN-BIND-1 study).
• Assessed DTI metrics (fractional anisotropy, mean, axial, radial diffusivity) at baseline, 2 weeks, and 8 weeks.
• Used region-of-interest analysis on 40 white matter regions and mixed-effects regression for temporal trends.

Main Results:

• Baseline axial diffusivity in the external capsule (superior longitudinal fasciculus) significantly associated with medication response.
• Responders showed baseline differences in cingulum, sagittal stratum, and corona radiata compared to nonresponders.
• Group differences also observed in internal capsule, posterior thalamic radiation, and uncinate fasciculus; no temporal changes noted.

Conclusions:

• DTI measures of white matter integrity at baseline can distinguish between antidepressant responders and nonresponders in MDD.
• These findings highlight the potential of DTI as a predictive biomarker for treatment response in depression.
• Further research can validate DTI for personalized antidepressant selection.